Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Yoshihiro Yagi"'
Autor:
Von Ralph Dane Marquez Herbuela, Tomonori Karita, Yoshiya Furukawa, Yoshinori Wada, Yoshihiro Yagi, Shuichiro Senba, Eiko Onishi, Tatsuo Saeki
BACKGROUND Children with profound intellectual and multiple disabilities (PIMD) or severe motor and intellectual disabilities (SMID) only communicate through movements, vocalizations, body postures, muscle tensions, or facial expressions on a pre- or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebdf26cd38cc330acb04087fd9fd1f16
https://doi.org/10.2196/preprints.28020
https://doi.org/10.2196/preprints.28020
Autor:
Eiko Onishi, Von Ralph Dane Marquez Herbuela, Yoshihiro Yagi, Tatsuo Saeki, Yoshinori Wada, Yoshiya Furukawa, Tomonori Karita, Shuichiro Senba
Publikováno v:
JMIR Rehabilitation and Assistive Technologies
JMIR Rehabilitation and Assistive Technologies, Vol 8, Iss 2, p e28020 (2021)
JMIR Rehabilitation and Assistive Technologies, Vol 8, Iss 2, p e28020 (2021)
Background Children with profound intellectual and multiple disabilities (PIMD) or severe motor and intellectual disabilities (SMID) only communicate through movements, vocalizations, body postures, muscle tensions, or facial expressions on a pre- or
Publikováno v:
The Mathematical Gazette. 89:283-287
Autor:
Yoshihiro Yagi, Haruhiko Yamasa, Toshiaki Ikeda, Tohru Tani, Mikio Saito, Kazuyoshi Hanasawa, Nobuhiko Koga, Naohiro Fujita, Hideki Shimaoka, Motoki Yonekawa, Toshiya Okahisa, Kimihiro Takayama, Izumi Amano, Muneo Ohta, Hitoshi Imaizumi, Masashi Kodama
Publikováno v:
World Journal of Surgery. 25:660-668
But: Evaluer le rapport entre les parametres cliniques et plasmatiques et les modifications d'activite d'endotoxines plasmatiques, d'une part, et l'utilisation de polymyxin B (PMX, Toray Medical Co., Ltd., Tokyo, Japon), un absorbant d'endotoxine, pe
Autor:
Toshiaki Iba, Yoshihiro Yagi, Hitoshi Tanaka, Yoshiaki Kaneshiro, Akio Kidokoro, Kenji Kaneko, Yoichi Ohno
Publikováno v:
Nihon Kyukyu Igakukai Zasshi. 9:45-52
実際の敗血症に近いモデルとして作製した微量エンドトキシン持続投与モデルを用いて,アンチトロンビンIIIによる臓器障害予防効果を検討した。方法:ラットに中心静脈カテーテルを挿
Autor:
Kunihiko Nagakari, Toshiaki Iba, Yoshihiro Yagi, Akio Kidokoro, Kitoji Takuhiro, Masaki Fukunaga, Fuminori Momose
Publikováno v:
Nihon Kyukyu Igakukai Zasshi. 9:294-300
プロテインCは血管内皮表面のトロンボモジュリンによって活性化される,ビタミンK依存性のタンパクで抗凝固,線溶活性化に中心的な役割を担っている。今回SIRSの基準を3日間以上連続し
Autor:
Toshiaki Iba, Kunihiko Nagakari, Akio Kidokoro, Fuminori Momose, Masaki Fukunaga, Yoshihiro Yagi
Publikováno v:
International Journal of Clinical Oncology. 2:197-201
Background This study was designed to determine whether 5-fluorouracil combined with intermittent low-dose cisplatin (cis-diaminedichloroplatinum, CDDP), a 5-fluorouracil modulator, would be an effective antitumor regimen.
Publikováno v:
Nihon Kyukyu Igakukai Zasshi. 8:103-110
Autor:
Yoichi Ohno, Akio Kidokoro, Yoshiaki Kaneshiro, Toshiaki Iba, Syoichi Fuse, Yoshihiro Yagi, Tadashi Akiyama
Publikováno v:
Nihon Kyukyu Igakukai Zasshi. 8:288-296
脂肪は効率のよい栄養源でありながら,長鎖脂肪(LCT)は免疫機能抑制や肝障害などの副作用のため,重症敗血症時には一般的に使用禁忌とされている。今回われわれは完全静脈栄養(TPN)施行
Autor:
Kunihiko Nagakari, Kitoji Takuhiro, Toshiaki Iba, Akio Kidokoro, Yoshihiro Yagi, Masaki Fukunaga
Publikováno v:
Nihon Kyukyu Igakukai Zasshi. 8:650-658
敗血症では比較的早期から過凝固状態が存在するが,これには単球/マクロファージや血管内皮細胞におけるtissue factor (TF)の表出による外因系凝固の活性化が考えられている。今回敗血症